| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-08-12 19:07:11 UTC |
|---|
| Update Date | 2022-03-07 02:49:18 UTC |
|---|
| HMDB ID | HMDB0003339 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | D-Glutamic acid |
|---|
| Description | There are two forms of glutamic acid found in nature: L-glutamic acid and D-glutamic acid. D-glutamic acid, is not endogenously produced in higher mammals. It is found naturally primarily in the cell walls of certain bacteria. D-glutamate is also present in certain foods e.g., soybeans and also arises from the turnover of the intestinal tract microflora, whose cell walls contain significant D-glutamate. Unlike other D-amino acids, D-glutamate is not oxidized by the D-amino acid oxidases, and therefore this detoxification pathway is not available for handling D-glutamate. Likewise, D-glutamic acid, when ingested, largely escapes most deamination reactions (unlike the L-counterpart). Free D-glutamate is found in mammalian tissue at surprisingly high levels, with D-glutamate accounting for 9% of the total glutamate present in liver. D-glutamate is the most potent natural inhibitor of glutathione synthesis identified to date and this may account for its localization to the liver, since circulating D-glutamate may alter redox stabiity (PMID 11158923 ). Certain eels are known to use D-glutamic acid as a phermone for chemical communication. D-Glutamic acid has been found to be a metabolite of Lactobacillus (PMID: 22754309 ). |
|---|
| Structure | InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (R)-2-Aminopentanedioic acid | ChEBI | | D-2-Aminoglutaric acid | ChEBI | | D-Glutaminic acid | ChEBI | | D-Glutaminsaeure | ChEBI | | DGL | ChEBI | | Glutamic acid D-form | ChEBI | | (R)-2-Aminopentanedioate | Generator | | D-2-Aminoglutarate | Generator | | D-Glutaminate | Generator | | Glutamate D-form | Generator | | D-Glutamate | Generator | | (2R)-2-Aminopentanedioate | HMDB | | (2R)-2-Aminopentanedioic acid | HMDB | | D-2-Aminopentanedioate | HMDB | | D-2-Aminopentanedioic acid | HMDB | | delta-2-Aminoglutarate | HMDB | | delta-2-Aminoglutaric acid | HMDB | | delta-2-Aminopentanedioate | HMDB | | delta-2-Aminopentanedioic acid | HMDB | | delta-Glutamate | HMDB | | delta-Glutamic acid | HMDB | | delta-Glutaminate | HMDB | | delta-Glutaminic acid | HMDB | | delta-Glutaminsaeure | HMDB | | Glutamate | HMDB | | Lopac-g-2128 | HMDB | | Lopac-gamma-2128 | HMDB | | R-(-)-Glutamate | HMDB | | R-(-)-Glutamic acid | HMDB | | Tocris-0217 | HMDB | | Glutamic acid, (D)-isomer | HMDB | | L Glutamic acid | HMDB | | L-Glutamate | HMDB | | L-Glutamic acid | HMDB | | D Glutamate | HMDB | | Glutamate, potassium | HMDB | | L-Glutamate, aluminum | HMDB | | Aluminum L glutamate | HMDB | | Glutamic acid | HMDB | | L Glutamate | HMDB | | Aluminum L-glutamate | HMDB | | Potassium glutamate | HMDB |
|
|---|
| Chemical Formula | C5H9NO4 |
|---|
| Average Molecular Weight | 147.1293 |
|---|
| Monoisotopic Molecular Weight | 147.053157781 |
|---|
| IUPAC Name | (2R)-2-aminopentanedioic acid |
|---|
| Traditional Name | D-glutamic acid |
|---|
| CAS Registry Number | 6893-26-1 |
|---|
| SMILES | N[C@H](CCC(O)=O)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 |
|---|
| InChI Key | WHUUTDBJXJRKMK-GSVOUGTGSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Glutamic acid and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Glutamic acid or derivatives
- Alpha-amino acid
- D-alpha-amino acid
- Amino fatty acid
- Dicarboxylic acid or derivatives
- Fatty acid
- Fatty acyl
- Amino acid
- Carboxylic acid
- Organic oxide
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 201 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 8.88 mg/mL at 25 °C | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.0 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.2343 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.62 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 400.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 484.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 318.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 40.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 195.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 67.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 287.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 220.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 836.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 584.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 39.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 677.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 198.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 277.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 725.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 480.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 478.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| D-Glutamic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O | 1507.5 | Semi standard non polar | 33892256 | | D-Glutamic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](N)CCC(=O)O | 1472.0 | Semi standard non polar | 33892256 | | D-Glutamic acid,1TMS,isomer #3 | C[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O | 1533.4 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O[Si](C)(C)C | 1518.9 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TMS,isomer #2 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O | 1617.6 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TMS,isomer #3 | C[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O[Si](C)(C)C | 1589.3 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TMS,isomer #4 | C[Si](C)(C)N([C@H](CCC(=O)O)C(=O)O)[Si](C)(C)C | 1729.5 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1625.8 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1664.7 | Standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1807.9 | Standard polar | 33892256 | | D-Glutamic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1779.5 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1718.7 | Standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1969.6 | Standard polar | 33892256 | | D-Glutamic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1765.0 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1708.5 | Standard non polar | 33892256 | | D-Glutamic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1949.2 | Standard polar | 33892256 | | D-Glutamic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1804.2 | Semi standard non polar | 33892256 | | D-Glutamic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1776.6 | Standard non polar | 33892256 | | D-Glutamic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1746.4 | Standard polar | 33892256 | | D-Glutamic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O | 1765.9 | Semi standard non polar | 33892256 | | D-Glutamic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](N)CCC(=O)O | 1743.3 | Semi standard non polar | 33892256 | | D-Glutamic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O | 1797.0 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1982.4 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 2094.9 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 2043.8 | Semi standard non polar | 33892256 | | D-Glutamic acid,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@H](CCC(=O)O)C(=O)O)[Si](C)(C)C(C)(C)C | 2168.8 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2272.6 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2259.4 | Standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2195.4 | Standard polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2433.4 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2321.6 | Standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2263.8 | Standard polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2427.8 | Semi standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2289.5 | Standard non polar | 33892256 | | D-Glutamic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2256.1 | Standard polar | 33892256 | | D-Glutamic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2668.5 | Semi standard non polar | 33892256 | | D-Glutamic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2533.6 | Standard non polar | 33892256 | | D-Glutamic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2243.6 | Standard polar | 33892256 |
|
|---|
| Spectra |
|---|
| |
|---|
| Biological Properties |
|---|
| Cellular Locations | - Cytoplasm (predicted from logP)
|
|---|
| Biospecimen Locations | - Blood
- Breast Milk
- Feces
- Saliva
- Urine
|
|---|
| Tissue Locations | - Epidermis
- Fibroblasts
- Intestine
- Neuron
- Placenta
- Spleen
- Testis
|
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.0140-0.200 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Breast Milk | Detected and Quantified | 1600 +/- 320 uM | Adult (>18 years old) | Female | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 880 +/- 680 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 490 +/- 390 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 11382 nmol/g wet feces | Adult (>18 years old) | Not Specified | Normal | | details | | Feces | Detected and Quantified | 8923 nmol/g wet feces | Adult (>18 years old) | Not Specified | Normal | | details | | Feces | Detected and Quantified | 11117 nmol/g wet feces | Adult (>18 years old) | Not Specified | Normal | | details | | Saliva | Detected and Quantified | 43.4 +/- 55.1 uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 8.91 +/- 3.90 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 123.84 +/- 110.2 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 67.51 +/- 75.14 uM | Adult (>18 years old) | Female | Normal | | details | | Saliva | Detected and Quantified | 13.5 +/- 8.75 uM | Adult (>18 years old) | Female | Normal | | details | | Saliva | Detected and Quantified | 14.5 +/- 19.8 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Saliva | Detected and Quantified | 14.5 +/- 6.75 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 14.9 +/- 7.60 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 7.9 +/- 3.9 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | <2.0 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | | Urine | Detected and Quantified | <2.0 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | | Urine | Detected and Quantified | <2.0 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 8.5 (3.3-18.4) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 2.6 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 156.0 +/- 90.0 uM | Adult (>18 years old) | Both | Schizophrenia | | details | | Blood | Detected and Quantified | 82.0 +/- 8.0 uM | Infant (0-1 year old) | Both | Premature | | details | | Blood | Detected and Quantified | 0.429 uM | Adult (>18 years old) | Not Specified | Gamma-glutamyltransferase deficiency | | details | | Blood | Detected and Quantified | 56.4 (12.69) uM | Adult (>18 years old) | Female | Pregnancy | | details | | Blood | Detected and Quantified | 52.21 (14.83) uM | Adult (>18 years old) | Female | Pregnancy with fetus having congenital heart defect | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative colitis | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative Colitis | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Crohn’s Disease | | details | | Saliva | Detected and Quantified | 47.82 +/- 18.36 uM | Adult (>18 years old) | Both | Lewy body disease | | details | | Saliva | Detected and Quantified | 43.79 +/- 10.57 uM | Adult (>18 years old) | Male | Frontotemporal lobe dementia | | details | | Saliva | Detected and Quantified | 38.26 +/- 29.05 uM | Adult (>18 years old) | Male | Alzheimer's disease | | details | | Urine | Detected and Quantified | 0.0064 umol/mmol creatinine | Adult (>18 years old) | Both | ADPKD | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Schizophrenia |
|---|
- Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2. [PubMed:17276036 ]
| | Pregnancy |
|---|
- Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1. [PubMed:24704061 ]
| | Gamma-glutamyltransferase deficiency |
|---|
- Schulman JD, Goodman SI, Mace JW, Patrick AD, Tietze F, Butler EJ: Glutathionuria: inborn error of metabolism due to tissue deficiency of gamma-glutamyl transpeptidase. Biochem Biophys Res Commun. 1975 Jul 8;65(1):68-74. [PubMed:238530 ]
| | Crohn's disease |
|---|
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| | Ulcerative colitis |
|---|
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| | Colorectal cancer |
|---|
- Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345. [PubMed:19006102 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
- Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762. [PubMed:27107423 ]
| | Irritable bowel syndrome |
|---|
- Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH: Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17. [PubMed:21330412 ]
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
| | Alzheimer's disease |
|---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| | Frontotemporal dementia |
|---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| | Lewy body disease |
|---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| | Autosomal dominant polycystic kidney disease |
|---|
- Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9. [PubMed:21389975 ]
|
|
|---|
| Associated OMIM IDs | - 181500 (Schizophrenia)
- 266600 (Crohn's disease)
- 114500 (Colorectal cancer)
- 104300 (Alzheimer's disease)
- 600274 (Frontotemporal dementia)
- 601313 (Autosomal dominant polycystic kidney disease)
|
|---|
| External Links |
|---|
| DrugBank ID | DB02517 |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB023148 |
|---|
| KNApSAcK ID | C00019577 |
|---|
| Chemspider ID | 21814 |
|---|
| KEGG Compound ID | C00217 |
|---|
| BioCyc ID | D-GLT |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Glutamic acid |
|---|
| METLIN ID | 6895 |
|---|
| PubChem Compound | 23327 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 15966 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | GLU_D |
|---|
| MarkerDB ID | MDB00000422 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Ozaki, Akio; Yagasaki, Makoto; Takada, Hideyoshi; Hashimoto, Yukio. Manufacture of D-glutamic acid with Lactobacillus. Jpn. Kokai Tokkyo Koho (1990), 4 pp. |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Emi M, Wilson DE, Iverius PH, Wu L, Hata A, Hegele R, Williams RR, Lalouel JM: Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem. 1990 Apr 5;265(10):5910-6. [PubMed:1969408 ]
- Persson H, Pelto-Huikko M, Metsis M, Soder O, Brene S, Skog S, Hokfelt T, Ritzen EM: Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells. Mol Cell Biol. 1990 Sep;10(9):4701-11. [PubMed:1697032 ]
- Ahlman B, Andersson K, Leijonmarck CE, Ljungqvist O, Hedenborg L, Wernerman J: Short-term starvation alters the free amino acid content of the human intestinal mucosa. Clin Sci (Lond). 1994 Jun;86(6):653-62. [PubMed:7914846 ]
- Wang M, Meng Z, Fu J: Synthesis and biodistribution of six novel 99mTc complexes of 2-hydroxybenzaldehyde-amino acid Schiff bases. Appl Radiat Isot. 2006 Feb;64(2):235-40. [PubMed:16309915 ]
- Majid SM, Liss AS, You M, Bose HR: The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene. 2006 Feb 2;25(5):756-68. [PubMed:16186799 ]
- Canal N, Nemni R: Autoimmunity and diabetic neuropathy. Clin Neurosci. 1997;4(6):371-3. [PubMed:9358982 ]
- Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW: Autoreactive T cells in healthy individuals. J Immunol. 2004 May 15;172(10):5967-72. [PubMed:15128778 ]
- Guariso G, Brotto F, Basso D, Alaggio R, Betterle C: Organ-specific autoantibodies in children with Helicobacter pylori infection. Helicobacter. 2004 Dec;9(6):622-8. [PubMed:15610075 ]
- Nagai A, Suzuki Y, Baek SY, Lee KS, Lee MC, McLarnon JG, Kim SU: Generation and characterization of human hybrid neurons produced between embryonic CNS neurons and neuroblastoma cells. Neurobiol Dis. 2002 Oct;11(1):184-98. [PubMed:12460557 ]
- Mally MI, Cirulli V, Hayek A, Otonkoski T: ICA69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia. 1996 Apr;39(4):474-80. [PubMed:8777998 ]
- Maechler P, Gjinovci A, Wollheim CB: Implication of glutamate in the kinetics of insulin secretion in rat and mouse perfused pancreas. Diabetes. 2002 Feb;51 Suppl 1:S99-102. [PubMed:11815466 ]
- Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST: No allelic variation in genes with high gliadin homology in patients with celiac disease and type 1 diabetes. Immunogenetics. 2004 Aug;56(5):375-8. Epub 2004 Aug 7. [PubMed:15309343 ]
- Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML, During MJ: Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science. 2002 Oct 11;298(5592):425-9. [PubMed:12376704 ]
- Meyer W, Poehling HM, Neurand K: Intraepidermal distribution of free amino acids in porcine skin. J Dermatol Sci. 1991 Sep;2(5):383-92. [PubMed:1742249 ]
- Cuervo JH, Rodriguez B, Houghten RA: The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity. Pept Res. 1988 Nov-Dec;1(2):81-6. [PubMed:2980783 ]
- Roll U, Scheeser J, Standl E, Ziegler AG: Alterations of lymphocyte subsets in children of diabetic mothers. Diabetologia. 1994 Nov;37(11):1132-41. [PubMed:7867885 ]
- Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP: Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15;175(10):7029-37. [PubMed:16272364 ]
- Raj D, Langford M, Krueger S, Shelton M, Welbourne T: Regulatory responses to an oral D-glutamate load: formation of D-pyrrolidone carboxylic acid in humans. Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E214-20. [PubMed:11158923 ]
- Zareian M, Ebrahimpour A, Bakar FA, Mohamed AK, Forghani B, Ab-Kadir MS, Saari N: A glutamic acid-producing lactic acid bacteria isolated from Malaysian fermented foods. Int J Mol Sci. 2012;13(5):5482-97. doi: 10.3390/ijms13055482. Epub 2012 May 7. [PubMed:22754309 ]
|
|---|